Fig. 2. Five-year actuarial recurrence rates (vaginal, pelvic, abdominal, and distant) for (A) low-, intermediate-, and high-risk stage II compared to corresponding stage I risk groups and (B) stage II patients lymph-node staged as compared to non-LN staged.

LN, lymph node.

^*p<0.05 testing low-, intermediate- and high-risk stage II patients against the corresponding stage I risk group; ^†p<0.05 using adjusted Cox analysis between either stage I or II or between stage II LN resected and not resected.